Skip to main content
ES
v1.2
Log in
C

Cipla

CIPLANSE
₹1,325.1-2.90 (-0.22%)as of 2026-10-16
Market Cap
₹1,06,634Cr.
P/E Ratio
29.8
P/B Ratio
3.11
EPS (TTM)
₹44.47
Day Range
₹1,315.1 – ₹1,337.5
Div Yield
0.98%
ROCE
15.5%
ROE
11.6%
52W Low: ₹1,16652W High: ₹1,673
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 7.0% a year over three years.
  • Debt is 0.02× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Cipla — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
5.5/ 10Overall
5/ 10Valuation
6/ 10Quality
6/ 10Fundamental
5/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 29.8P/E: 29.8 | P/B: 3.11
Growth
ModestSales CAGR — 3Y: 7% · 1Y: 2%
Profitability
ModerateROCE: 15.5% | ROE: 11.6%

Key Metrics

Valuation
PEG Ratio 2.98
Price / Sales 3.76x
Price / FCF 114.9x
Book Value ₹426
Margins & returns
Operating Margin 19%
Net Margin 11.8%
Return on Assets 7.9%

Frequently Asked Questions

MarketsPortfolioChart